About-cancer / lapaʻau / lāʻau / melanoma

Ua ʻae ʻia nā lāʻau no Melanoma

Ua helu ʻia kēia ʻaoʻao i nā lāʻau lapaʻau maʻi ʻaʻai i ʻae ʻia e ka Food and Drug Administration (FDA) no melanoma. Loaʻa i ka papa inoa nā inoa generic a me nā inoa inoa. Loulou nā inoa lāʻau i nā hōʻuluʻulu manaʻo ʻike maʻi maʻi ʻo NCI. Hiki paha i nā lāʻau i hoʻohana ʻia i ka melanoma i helu ʻole ʻia ma aneʻi.

Ua ʻae ʻia nā lāʻau no Melanoma

Aldesleukin

Binimetinib

ʻO Braftovi (Encorafenib)

ʻO Cobimetinib

ʻO Cotellic (Cobimetinib)

ʻO Dabrafenib Mesylate

ʻO Dacarbazine

Encorafenib

IL-2 (Aldesleukin)

Imlygic (Talimogene Laherparepvec)

Interleukin-2 (Aldesleukin)

Intron A (Recombinant Interferon Alfa-2b)

Ipilimumab

Keytruda (Pembrolizumab)

Mekinist (Trametinib)

Mektovi (Binimetinib)

ʻO Nivolumab

Opdivo (Nivolumab)

Peginterferon Alfa-2b

PEG-Intron (Peginterferon Alfa-2b)

Pembrolizumab

Proleukin (Aldesleukin)

ʻO Recombinant Interferon Alfa-2b

Sylatron (Peginterferon Alfa-2b)

Tafinlar (Dabrafenib Mesylate)

ʻO Talimogene Laherparepvec

Trametinib

ʻO Vemurafenib

Yervoy (Ipilimumab)

Zelboraf (Vemurafenib)